About Genesis Laboratories India Private Limited
Data last updated:
Genesis Laboratories India Private Limited was a foreign private limited company based in Patna, Bihar, India, operated as a subsidiary of Genesis Laboratories Inc. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 16 July 2013.
The company was registered with the Registrar of Companies (ROC), Patna, under CIN U74999BR2013FTC020762.
The company had an authorised share capital of ₹4.5 Cr and a paid-up capital of ₹4.41 Cr. It was led by directors Richard Poche Michael and Rajesh Babu Garlapati.
Its last annual general meeting (AGM) was held on 31 July 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office was at Patna, Bihar.
The company has 4 deals on record (4 funding rounds), with disclosed funding of ₹4.4 Cr; the latest was in February 2019.
The last known website on record is genesislabs.com.
Company details
Contact details
Genesis Laboratories India Private Limited's registered office is in Patna, Bihar. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat No. 101 102 & 103 1st Floor Mantra Vihar Sardar Patel Path Srikrishnapuri Borin, G Road, Patna, Bihar, India – 800013
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Genesis Laboratories India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Genesis Laboratories India Private Limited
FY 2020 filings availableFinancial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ||||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ||||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | ||||
| Net Profit Margin | ||||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Genesis Laboratories India Private Limited, buy the company report.
Board of directors of Genesis Laboratories India Private Limited
Genesis Laboratories India has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Richard Poche Michael | Additional Director | 30 Aug 2018 | 8 Years 2 Months | As last reported |
| Rajesh Babu Garlapati | Additional Director | 01 Dec 2018 | 7 Years 11 Months | As last reported |
Auditor
Genesis Laboratories India Private Limited is audited by Ruchi Anand & Associates for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Ruchi Anand & Associates | FY 2018 | 016790N |
Shareholding
The shareholding of Genesis Laboratories India Private Limited is on record for 4 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Genesis Laboratories India Private Limited, buy the company report.
Deals & funding
Genesis Laboratories India Private Limited has 4 deals on record (4 funding rounds), with disclosed funding of ₹4.4 Cr; the latest was in February 2019.
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2019 | Funding round | ₹11.1 Lakh | Investors: Genesis Laboratories Inc |
| Jul 2017 | Funding round | ₹1.07 Cr | Investors: Genesis Laboratories Inc |
| Dec 2015 | Funding round | ₹2.98 Cr | Investors: Genesis Laboratories Inc |
| May 2014 | Funding round | ₹23.8 Lakh | Investors: Genesis Laboratories Inc |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Genesis Laboratories India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Genesis Laboratories India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Genesis Laboratories India Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Genesis Laboratories India Private Limited has 4 board changes on record since 2018: 2 appointments and 2 cessations. The latest: Gary Wayne Callahan ceased to be Director on 24 Apr 2019.
Frequently asked questions
Genesis Laboratories India has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Genesis Laboratories India was a foreign private limited company based in Patna, Bihar, India. The company worked in pharma contract r and d, within the pharma industry. It was incorporated on 16 July 2013 and is registered under CIN U74999BR2013FTC020762. The company has been struck off by the Registrar of Companies and is no longer operational.
Genesis Laboratories India had 2 directors:
- Richard Poche Michael - Additional Director
- Rajesh Babu Garlapati - Additional Director
The CIN (Corporate Identification Number) of Genesis Laboratories India is U74999BR2013FTC020762. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Genesis Laboratories India is at Flat No. 101 102 & 103 1st Floor Mantra Vihar Sardar Patel Path Srikrishnapuri Borin, G Road, Patna, Bihar, India – 800013.
Genesis Laboratories India was incorporated on 16 July 2013. It is registered with the Registrar of Companies, Patna.
Genesis Laboratories India can be reached through the website genesislabs.com. Its registered office is in Patna, Bihar, India.
The latest financial statements of Genesis Laboratories India on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 July 2020. Year-wise statements from 2015 are in the company report.
Genesis Laboratories India operated in the pharma industry, in the pharma contract r and d segment. It worked in this industry before it was struck off.
Genesis Laboratories India has 4 deals on record (4 funding rounds), with disclosed funding of ₹4.4 Cr; the latest was in February 2019.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
